ArticleHuman vaccines & immunotherapeutics2022
Cost-utility analysis of the universal pneumococcal vaccination programme for older adults in Norway.
Liv Solvår Nymark et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it